Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Jan. 21, 2021, 4:31 p.m. EST

Moderna Inc. stock outperforms competitors on strong trading day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA advanced 6.26% to $132.98 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.55% to 13,530.91 and the Dow Jones Industrial Average DJIA falling 0.04% to 31,176.01. This was the stock's second consecutive day of gains. Moderna Inc. closed $45.52 short of its 52-week high ($178.50), which the company achieved on December 1st.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV fell 1.21% to $111.26, Amgen Inc. AMGN fell 0.13% to $252.03, and AstraZeneca PLC ADR AZN rose 0.59% to $52.55. Trading volume (20.8 M) remained 6.4 million below its 50-day average volume of 27.1 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.